[Chemo-induced mucositis in pediatric oncology: Perspectives?]

Bull Cancer. 2021 Jul-Aug;108(7-8):761-770. doi: 10.1016/j.bulcan.2021.01.018. Epub 2021 Apr 28.
[Article in French]

Abstract

Mucositis is defined as inflammatory and/or ulcerative lesions of the oral and/or gastrointestinal tract. It occurs in approximately 40% to 50% of adults patients receiving conventional chemotherapy and up to 75% of patients receiving high dose chemotherapy as conditioning for hematopoietic stem cell transplantation. It is a toxic side effect, which strongly impairs quality of life and leads to refractory pain, increasing risk of infection and even therapeutic modifications. Despite improvements made, the management of mucositis remains a challenge and is still not consensual. A multicentric survey of practices concerning the preventive and curative management of chemo-induced mucositis in pediatric oncology department in France was carried out using a standardized questionnaire. Results confirm heterogeneous practices and the small progress made during the last decade. This national survey and an analysis of the recent literature leads to propose guidelines for the prevention and treatment of oral mucositis in children receiving treatment for cancer.

Keywords: Children; Guidelines; Mucite; Mucositis; Oncologie; Oncology; Pédiatrie; Recommandations.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Cancer Care Facilities / statistics & numerical data
  • Child
  • France
  • Health Care Surveys / statistics & numerical data
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Laser Therapy / methods
  • Mucositis / chemically induced*
  • Mucositis / complications
  • Mucositis / microbiology
  • Mucositis / prevention & control
  • Oral Hygiene
  • Pain Management
  • Practice Patterns, Physicians' / standards*
  • Quality of Life
  • Transplantation Conditioning / adverse effects

Substances

  • Antineoplastic Agents